Weir, Christopher J.

Adaptive designs in clinical trials: why use them, and how to run and report them

Pallmann, P., Bedding, A. W., Choodari-Oskooei, B., Dimairo, M., Flight, L., Hampson, L. V., Holmes, J., Mander, A. P., Odondi, L., Sydes, M. R., et al. (2018) · BMC Medicine

Statistical Methods in Clinical TrialsStatistical Methods and Bayesian Inference

Cited by 829

Does the Prevention of Complications Explain the Survival Benefit of Organized Inpatient (Stroke Unit) Care?: Further Analysis of a Systematic Review

Govan, L., Langhorne, P., & Weir, C. J. (2007) · Stroke

Acute Ischemic Stroke ManagementStroke Rehabilitation and Recovery

Cited by 168

Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial

Weir, C. J., & Lees, K. R. (2003) · Statistics in Medicine

Statistical Methods in Clinical TrialsOptimal Experimental Design Methods

Cited by 102

METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research

METACOHORTS Consortium, Dichgans, M., Wardlaw, J., Smith, E., Zietemann, V., Seshadri, S., Sachdev, P., Biessels, G. J., Fazekas, F., Benavente, O., et al. (2016) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

Cited by 101

Early PREdiction of sepsis using leukocyte surface biomarkers: the ExPRES-sepsis cohort study

Shankar-Hari, M., Datta, D., Wilson, J., Assi, V., Stephen, J., Weir, C. J., Rennie, J., Antonelli, J., Bateman, A., Felton, J. M., et al. (2018) · Intensive Care Medicine

Sepsis Diagnosis and TreatmentInflammation biomarkers and pathways

Cited by 74

Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial)

Morrison, E. E., Oatey, K., Gallagher, B., Grahamslaw, J., O'Brien, R., Black, P., Oosthuyzen, W., Lee, R. J., Weir, C. J., Henriksen, D., et al. (2019) · eBioMedicine

Drug-Induced Hepatotoxicity and ProtectionPoisoning and overdose treatments

Cited by 48

Improving Trial Power Through Use of Prognosis-Adjusted End Points

Young, F. B., Lees, K. R., & Weir, C. J. (2005) · Stroke

Statistical Methods in Clinical TrialsAcute Ischemic Stroke Management

Cited by 44

Sensitive troponin assay predicts outcome in syncope

Reed, M. J., Mills, N. L., & Weir, C. J. (2012) · Emergency Medicine Journal

Acute Myocardial Infarction ResearchCardiovascular Syncope and Autonomic Disorders

Cited by 33

Targeting Neuroprotection Clinical Trials to Ischemic Stroke Patients With Potential to Benefit From Therapy

Weir, C. J., Kaste, M., & Lees, K. R. (2004) · Stroke

Acute Ischemic Stroke ManagementStatistical Methods in Clinical Trials

Cited by 31

Diagnostic yield of an ambulatory patch monitor in patients with unexplained syncope after initial evaluation in the emergency department: the PATCH-ED study

Reed, M. J., Grubb, N. R., Lang, C. C., Gray, A. J., Simpson, K., MacRaild, A., & Weir, C. J. (2018) · Emergency Medicine Journal

Cardiovascular Syncope and Autonomic DisordersCardiac electrophysiology and arrhythmias

Cited by 28

Coupling cognitive and brainstem dysfunction in multiple sclerosis-related chronic neuropathic limb pain

Foley, P., Kong, Y., Dirvanskiene, R., valdes-Hernandez, M., Bastiani, M., Murnane, J., Sellar, R., Roberts, N., Pernet, C., Weir, C., et al. (2022) · Brain Communications

Pain Mechanisms and TreatmentsMultiple Sclerosis Research Studies

Cited by 11